1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-930
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Label - 71610 0930 30
  2. Aphena - Aphena
  3. Chemical Structure - pregabalin 01
  4. Figure 1 - pregabalin 02
  5. Figure 2 - pregabalin 03
  6. Figure 3 - pregabalin 04
  7. Figure 4 - pregabalin 05
  8. Figure 5 - pregabalin 06
  9. Figure 6 - pregabalin 07
  10. Figure 7 - pregabalin 08
  11. Figure 8 - pregabalin 09
  12. Figure 9 - pregabalin 10
  13. Figure 10 - pregabalin 11
  14. Figure 11 - pregabalin 12
  15. Figure 12 - pregabalin 13

Product Label Images

The following 15 images provide visual information about the product associated with Pregabalin NDC 71610-930 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 71610 0930 30

Label - 71610 0930 30

This is a list of pharmaceutical items, including "Casmins" and "Pregabalin". The text also contains a reference number (71610-630-30) and pricing information (£1). Additionally, there are mentions of "Capaues" and a code possibly related to the product.*

Aphena - Aphena

Aphena - Aphena

Chemical Structure - pregabalin 01

Chemical Structure - pregabalin 01

Figure 1 - pregabalin 02

Figure 1 - pregabalin 02

Figure 2 - pregabalin 03

Figure 2 - pregabalin 03

Figure 3 - pregabalin 04

Figure 3 - pregabalin 04

Figure 4 - pregabalin 05

Figure 4 - pregabalin 05

Percent of Patients Improved This text appears to be showing the percentage of patients improved after taking different doses of Pregabalin and a placebo for pain relief. The patients were given Pregabalin 200 mg three times a day, Pregabalin 100 mg three times 2 a day, and a placebo. The chart may indicate the improvement in pain from baseline for each group of patients.*

Figure 5 - pregabalin 06

Figure 5 - pregabalin 06

Figure 6 - pregabalin 07

Figure 6 - pregabalin 07

Figure 7 - pregabalin 08

Figure 7 - pregabalin 08

Figure 8 - pregabalin 09

Figure 8 - pregabalin 09

This text provides information on responder rates at different dosages in a study. The responder rates are shown in percentages for different groups receiving a placebo and varying doses of a medication. The rates range from 22.6% to 60% for different dosages.*

Figure 9 - pregabalin 10

Figure 9 - pregabalin 10

Figure 10 - pregabalin 11

Figure 10 - pregabalin 11

Figure 11 - pregabalin 12

Figure 11 - pregabalin 12

This is a report showing the percentage of subjects who have improved over time, specifically from baseline to week 12 in a study involving the drug Pregabalin. The list includes various percentages such as 20, 22, 40, 90, and 100.*

Figure 12 - pregabalin 13

Figure 12 - pregabalin 13

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.